JORVEZA
Identification of Jorveza
| No description |
Google image searchProduct monograph
Active ingredient
budesonide, 0.5 MG
DIN: 02513854
Dosage form(s): TABLET (ORALLY DISINTEGRATING)
Route(s) of administration: ORAL
Schedule: Prescription
Company: AVIR PHARMA INC.
Date: 19-OCT-2021
ATC:
- A07 — ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS (ATC, ATC/DDD, )
- A07E — INTESTINAL ANTIINFLAMMATORY AGENTS (ATC, ATC/DDD)
- A07EA — Corticosteroids acting locally (ATC, ATC/DDD)
- A07EA06 — BUDESONIDE (ATC/DDD)
Reference brand drug: Jorveza, Entocort
